<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31176" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Virchow Triad</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kushner</surname>
            <given-names>Abigail</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>West</surname>
            <given-names>William P.</given-names>
          </name>
          <aff>UPMC Lititz</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khan Suheb</surname>
            <given-names>Mahammed Z.</given-names>
          </name>
          <aff>University of Wisconsin</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pillarisetty</surname>
            <given-names>Leela Sharath</given-names>
          </name>
          <aff>Midland Memorial / Texas Tech University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Abigail Kushner declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>William West declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mahammed Khan Suheb declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Leela Sharath Pillarisetty declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>6</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31176.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Vascular thrombi are formed in low flow and shear stress, mainly consisting of fibrin strands, red blood cells, and a few platelets. In 1856, Rudolf Virchow, a renowned Berlin scientist and physician, recognized these factors due to his extensive work on venous thrombosis.<xref ref-type="bibr" rid="article-31176.r1">[1]</xref>&#x000a0;These concepts evolved over the years and are relevant to developing arterial thrombosis.<xref ref-type="bibr" rid="article-31176.r2">[2]</xref>&#x000a0;Rudolf Virchow&#x000a0;is&#x000a0;1 of the first physicians to describe the concept at a cellular level, believing that most conditions, including pathological thrombosis, were caused by cellular pathology.<xref ref-type="bibr" rid="article-31176.r3">[3]</xref> He is known as the "father of modern pathology," Virchow was a physician, scientist, anthropologist, prehistorian, and biologist in addition to his endeavors in&#x000a0;pathology. In addition, he received credit for his work in cellular biology and early cancer research. He theorized the left supraclavicular lymph node (now called Virchow's node), when enlarged and hard on palpation, is associated with gastric cancer.<xref ref-type="bibr" rid="article-31176.r3">[3]</xref> Charles Emile Troisier later recognized the further association of other abdominal cancers and testicular cancer with the presence of Virchow's node.<xref ref-type="bibr" rid="article-31176.r4">[4]</xref></p>
        <p>Virchow sought to explain the causation of pulmonary thromboembolism and theorized that pulmonary arterial embolus arises from peripheral/distant thrombosis. He attempted to explain the mechanism or define the conditions necessary to initiate peripheral clotting and how a thrombus may dislodge from a peripheral vein, travel to the right heart, and enter the pulmonary arterial system. The&#x000a0;3 factors of Virchow's triad include intravascular vessel wall damage, stasis of flow, and a hypercoagulable state.<xref ref-type="bibr" rid="article-31176.r1">[1]</xref> Understanding these factors involved in thrombus formation and subsequent thromboembolic events enables the clinician to stratify risk, direct clinical decision-making regarding treatment, and establish preventative measures.&#x000a0;Virchow died from cardiac disease on September 5, 1902, after sustaining a femur fracture.<xref ref-type="bibr" rid="article-31176.r3">[3]</xref> His main contributions to medicine emanated from his observational skills and abilities to accurately deduce cellular processes contributing to health and disease. Many of his observations remain accurate to this day, and scientists are, in many instances, only beginning to unravel the molecular pathways underlying the observations made by this physician nearly 150 years ago.</p>
        <p>In theory, Virchow's triad postulates&#x000a0;3 factors predisposing a person to develop vascular thrombosis. These factors include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypercoagulability of blood</p>
          </list-item>
          <list-item>
            <p>Alteration in blood flow in the vessels</p>
          </list-item>
          <list-item>
            <p>Vessel wall injury/ Endothelial damage</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31176.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Thrombosis, by definition, is the formation of a clot within a blood vessel.&#x000a0;As described earlier, Virchow's triad represents&#x000a0;3 qualities in physiology that can result in thrombosis. These include:</p>
        <p>
<bold>Endothelial Damage</bold>
</p>
        <p>A healthy endothelium provides an anticoagulant and anti-platelet surface with certain cell surface glycoproteins and the release of various molecules, some of which are stored pre-formed in specialized and unique Weibel-Palade bodies.<xref ref-type="bibr" rid="article-31176.r5">[5]</xref><xref ref-type="bibr" rid="article-31176.r6">[6]</xref> Examples of glycoproteins include thrombomodulin, tissue factor, and ectonucleotidase(s) that act as a receptor for thrombin, as an initiator of coagulation by its interaction with coagulation factor VII, and minimize the prothrombotic effects of nucleotides such as ADP.<xref ref-type="bibr" rid="article-31176.r7">[7]</xref> However, various pathological processes can cause the cleavage or shedding of these molecules from the cell surface. The molecules can be measured in the blood using the ELISA technique. Thus,&#x000a0;1&#x000a0;feature of a damaged or dysfunctional endothelium is increased plasma levels of various molecules normally present as part of the cell membrane.&#x000a0;As membrane thrombomodulin has anticoagulant properties, its loss from the cell surface may tip hemostasis towards pro-coagulation.<xref ref-type="bibr" rid="article-31176.r8">[8]</xref><xref ref-type="bibr" rid="article-31176.r9">[9]</xref>&#x000a0;</p>
        <p>Nevertheless, since increased levels of all the plasma forms of cell surface molecules are found in atherothrombotic disease, it may be presumed that they reflect a shift towards thrombosis.<xref ref-type="bibr" rid="article-31176.r10">[10]</xref>&#x000a0;The endothelium also secretes/releases various molecules that may be active in thrombosis and hemostasis. Among these are the von Willebrand factor, tissue plasminogen activator antigen factor, and fibrinogen; high levels have repeatedly been shown to predict major cardiovascular events.<xref ref-type="bibr" rid="article-31176.r11">[11]</xref><xref ref-type="bibr" rid="article-31176.r12">[12]</xref><xref ref-type="bibr" rid="article-31176.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Damage to a vessel's endothelial wall alters blood flow dynamics. Endothelial disturbance can result from insults such as smoking, chronically elevated blood pressure, and atherosclerotic disease secondary to hyperlipidemia. When an insult to the wall occurs, flow disruption or "turbulence" occurs. Turbulent flow within a vessel occurs when the blood flow rate becomes too rapid or blood flow passes over an affected surface; this creates disordered flow and eddy currents, increasing the flow friction within a vessel. Reynolds number can represent the tendency for turbulence to occur.<xref ref-type="bibr" rid="article-31176.r2">[2]</xref><xref ref-type="bibr" rid="article-31176.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Re = (v x d x p) / n</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Where v = mean velocity, d = diameter (in centimeters), n = viscosity (in poise), and p = density.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Turbulence within the vessel may occur due to various factors, such as irregular atheromas from plaque formation, bifurcations in the vessel, and areas of stenosis, most prominent in patients with vascular disease.<xref ref-type="bibr" rid="article-31176.r2">[2]</xref><xref ref-type="bibr" rid="article-31176.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Alteration in Blood Flow</bold>
</p>
        <p>In streamlined (laminar) flow, endothelial cell morphology and function are affected by the shear stresses, and accordingly, to minimize this, they elongate and align in the direction of flow.<xref ref-type="bibr" rid="article-31176.r15">[15]</xref> The secretion and release of endothelial defenses such as nitric oxide, prostacyclin, and tissue plasminogen activator depend on the stressors on the vessel wall. Thereby, in the event of an endothelial injury, the blood flow regulates vascular reactivity and confines platelet adhesion, aggregation, and fibrin formation to sites of endothelial injury.<xref ref-type="bibr" rid="article-31176.r16">[16]</xref> Additionally, the synthesis and release of prothrombotic and proinflammatory endothelial mediators such as tissue factor, von Willebrand factor, endothelin, ICAM-1, and VCAM-1 depend on the vessel wall stress.<xref ref-type="bibr" rid="article-31176.r17">[17]</xref>&#x000a0;Evidence shows that some endothelial mediators influencing vessel wall reactivity are under genetic control.<xref ref-type="bibr" rid="article-31176.r16">[16]</xref> As the central (axial) flow is disrupted, numerous red blood cells, leucocytes, and platelets get strategically concentrated near the vessel wall for adhesion and activation.<xref ref-type="bibr" rid="article-31176.r17">[17]</xref> High shear forces at the vessel wall further activate platelets via the release of von Willebrand factor and promote their adhesion to the exposed subendothelium.&#x000a0;Hence, stasis (induced by internal or external pressure) is required to allow fibrin formation and secondary hemostasis.</p>
        <p>Atherogenesis occurs preferentially at arterial bifurcations and bends; at these sites, flow separation results in areas of low-flow, low-shear recirculation of blood cells and proteins in contact with the vessel wall. Such flow conditions favor the adhesion of platelets and monocytes, as well as the infiltration of plasma components such as low-density lipoprotein cholesterol and fibrinogen, causing the development of a plague.<xref ref-type="bibr" rid="article-31176.r18">[18]</xref> This mechanical blockade in the arterial vessel wall leads to high intravascular shear stress at the site of the stenotic lesion. Arterial thrombosis usually follows the rupture of atherosclerotic plaques and is the most common pathophysiological process in acute coronary syndromes, ischaemic stroke, and critical leg ischemia.<xref ref-type="bibr" rid="article-31176.r19">[19]</xref> High intra-stenotic shear stresses may be&#x000a0;1 factor in promoting arterial plaque rupture. High-shear activation of blood platelets may promote the initial platelet-rich "white head" of arterial thrombi. Distal to the atherothrombotic stenosis, low-shear stresses may promote the subsequent, fibrin-and-red-cell-rich "red tail."<xref ref-type="bibr" rid="article-31176.r19">[19]</xref>&#x000a0;Some examples of blood flow alteration&#x000a0;include atrial fibrillation,&#x000a0;left ventricle&#x000a0;wall akinesis, valvular heart disease, prolonged immobility such as bedridden patients or prolonged travel, surgery, and trauma.<xref ref-type="bibr" rid="article-31176.r2">[2]</xref><xref ref-type="bibr" rid="article-31176.r20">[20]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>&#x000a0;When an insult to the wall occurs, flow disruption or "turbulence" occurs. Turbulent flow within a vessel occurs when the blood flow rate becomes too rapid or blood flow passes over an affected surface; this creates disordered flow and eddy currents, increasing the flow friction within a vessel. Reynolds number can represent the tendency for turbulence to occur.<xref ref-type="bibr" rid="article-31176.r2">[2]</xref><xref ref-type="bibr" rid="article-31176.r14">[14]</xref></p>
          </list-item>
          <list-item>
            <p>Re = (v x d x p) / n</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Where v = mean velocity, d = diameter (in centimeters), n = viscosity (in poise), and p = density.</p>
              </list-item>
            </list>
          </list-item>
          <list-item>
            <p>Turbulence within the vessel may occur due to various factors, such as irregular atheromas from plaque formation, bifurcations in the vessel, and areas of stenosis, most prominent in patients with vascular disease.<xref ref-type="bibr" rid="article-31176.r2">[2]</xref><xref ref-type="bibr" rid="article-31176.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Hypercoagulability of Blood&#x000a0;</bold>
</p>
        <p>The constituents of blood are many and varied, but soluble coagulation factors (such as fibrinogen and tissue factors) and cells (such as platelets) are implicated in thrombosis. Understandably, a continuum exists between healthy and hemostatic abnormalities in prothrombotic or hypercoagulable states and 'overtly' increased clotting in acute thrombosis.&#x000a0;</p>
        <p>
<bold>Platelets</bold>
</p>
        <p>The role of platelets in the pathogenesis of atherosclerosis and as a constituent of atheroma is well elucidated. Platelet function can be quantified by its tendency to aggregate and measure its levels in urine and plasma. The alpha granule constituents (beta thromboglobulin, platelet factor 4) and the adhesion molecule P-selectin can be measured in the plasma. The platelet factor 4 competes with antithrombin III for binding to heparan glycosaminoglycans, thereby impairing heparan-catalyzed inhibition of thrombin.&#x000a0;Raised levels of various platelet molecules are abnormal in cancer, peripheral disease, acute myocardial infarction, diabetes, and hypertension.<xref ref-type="bibr" rid="article-31176.r21">[21]</xref><xref ref-type="bibr" rid="article-31176.r22">[22]</xref>&#x000a0;The adhesion molecule P-selectin (CD62P) is of particular interest because of its role in modulating interactions between blood cells and the endothelium and the possible use of the soluble form as a plasma predictor of adverse cardiovascular events. For example, it is known that thrombin induces surface expression of P-selection on platelets.<xref ref-type="bibr" rid="article-31176.r23">[23]</xref> Although present on the external cell surface of both activated endothelium and activated platelets, it now seems clear that most, if not all, of the measured plasma P-selectin is of platelet origin.<xref ref-type="bibr" rid="article-31176.r23">[23]</xref> P-selectin is also partially responsible for the adhesion of certain leukocytes and platelets to the endothelium. Increased P-selectin expression has been demonstrated on active atherosclerotic plaques.<xref ref-type="bibr" rid="article-31176.r24">[24]</xref></p>
        <p>
<bold>Fibrinogen&#x000a0;</bold>
</p>
        <p>Thrombogenesis is finely balanced between coagulation and fibrinolytic pathways.&#x000a0;The fibrinolytic system is primarily influenced by the interaction between plasminogen activators (such as tissue plasminogen activators) and inhibitors that modulate this activity (eg, plasminogen activator inhibitor, PAI-1). Plasma fibrinogen is the primary determinant of blood viscosity and blood flow. It affects the aggregation of platelets, interacts with plasminogen binding, and mediates the final steps of clot formation after it combines with thrombi.&#x000a0;</p>
        <p>
<bold>Fibrin D-dimer Levels</bold>
</p>
        <p>Raised levels of fibrin D-dimer are fibrin degradation products, an index of intravascular thrombogenesis, and fibrin turnover.</p>
      </sec>
      <sec id="article-31176.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The function of Virchow's triad is to demonstrate the underlying physiology that drives the formation of a thrombus. Clots within the vasculature place the patient at risk for thromboembolic events such as CVA, pulmonary arterial embolus or organ infarction, ischemia, and cell death. Understanding physiology enables clinicians to understand better the risk factors for developing deep vein thrombosis.&#x000a0;</p>
        <p>
<bold>Thrombogenesis in Deep Vein Thrombosis (DVT)</bold>
</p>
        <p>The simultaneous presence of venous stasis, hypercoagulability, and vascular injury increases the risk for clot formation, as described in Virchow's triad. Venous thrombosis tends to occur in areas with decreased or mechanically altered blood flow, such as the pockets adjacent to valves in the leg's deep veins.<xref ref-type="bibr" rid="article-31176.r25">[25]</xref> While valves help to promote blood flow through the venous circulation, they are also potential locations for venous stasis and hypoxia. Multiple postmortem studies have demonstrated the propensity for venous thrombi to form in the sinuses adjacent to venous valves.<xref ref-type="bibr" rid="article-31176.r26">[26]</xref><xref ref-type="bibr" rid="article-31176.r27">[27]</xref>&#x000a0;The hypercoagulable micro-environment may downregulate certain antithrombotic proteins preferentially expressed on venous valves, including thrombomodulin and endothelial protein C receptor.<xref ref-type="bibr" rid="article-31176.r28">[28]</xref> In addition to reducing important anticoagulant proteins, hypoxia drives the expression of certain procoagulants. Among these is P-selectin, an adhesion molecule that attracts immunologic cells containing tissue factors to the endothelium.<xref ref-type="bibr" rid="article-31176.r29">[29]</xref><xref ref-type="bibr" rid="article-31176.r30">[30]</xref>&#x000a0;A venous thrombus has&#x000a0;2 components: an inner platelet-rich white thrombus forming the so-called lines of Zahn, surrounded by an outer red cell-dense fibrin clot. Fibrin and extracellular DNA complexed with histone proteins form the outer scaffold, which may be important in determining thrombus susceptibility to tissue plasminogen activator and thrombolysis.<xref ref-type="bibr" rid="article-31176.r30">[30]</xref> As the ratio of procoagulants to anticoagulants increases, so does the risk of thrombus formation. The proportion of proteins is partly determined by the ratio of the endothelial cell surface to blood volume. A decreased cell surface-to-blood volume ratio (ie, large vessels) favors procoagulants.<xref ref-type="bibr" rid="article-31176.r31">[31]</xref> Factor VIII, von Willebrand factor, factor VII, and prothrombin seem particularly influential in tipping the scale towards coagulation.<xref ref-type="bibr" rid="article-31176.r32">[32]</xref></p>
        <p>In addition to promoting thrombin generation, prothrombin inhibits the anticoagulant properties of activated protein C, thereby dampening a natural anticoagulant pathway. There are&#x000a0;3 pathways: the protein C anticoagulant pathway (protein C, protein S, thrombomodulin, and perhaps endothelial protein C receptor), the heparin-antithrombin pathway, and the tissue factor inhibitor pathway. Defects in these pathways are associated with an increased risk for thrombus formation. In humans, less is known regarding the role of the tissue factor inhibitor pathway.<xref ref-type="bibr" rid="article-31176.r32">[32]</xref><xref ref-type="bibr" rid="article-31176.r33">[33]</xref>&#x000a0;Several familial variants predispose to thrombus formation by increasing the levels of factors VII, VIII, IX, von Willebrand factor, and prothrombin. Other risk factors for clot formation include cancer, oral contraceptives, obesity, and advancing age. Malignancy can exert a compressive effect on veins, contributing to stasis. It also leads to shedding procoagulants, such as tissue factor on membrane particles, which promotes thrombosis.<xref ref-type="bibr" rid="article-31176.r34">[34]</xref> Obesity and oral contraceptive use are independent risk factors for thrombosis. Together, they increase thrombosis risk synergistically.<xref ref-type="bibr" rid="article-31176.r35">[35]</xref></p>
        <p>Finally, advancing age is associated with an increased risk for thrombosis. While the cause for this remains unsettled, several factors related to aging have been observed: greater prevalence of obesity, increased frequency of illness and periods of prolonged immobility, comorbid medical conditions, and an increase in the level of procoagulants without a commensurate increase in anticoagulants such as protein C.<xref ref-type="bibr" rid="article-31176.r27">[27]</xref> Thrombosis formation is a dynamic, multicausal process that hinges on a fine balance of physical and biochemical factors.</p>
        <p>
<bold>Thrombogenesis in Pregnancy&#x000a0;</bold>
</p>
        <p>- Progesterone causes systemic venous dilation.<xref ref-type="bibr" rid="article-31176.r36">[36]</xref> Consequently, renal vasodilatation leads to an increase in systemic volume and Na retention. This rise in venous blood volume and pressure, along with resulting distension of the vessels, led to stasis and increased lower extremity edema.<xref ref-type="bibr" rid="article-31176.r37">[37]</xref> However, it has been proposed that, unlike VTE in the general population, VTE in pregnancy may start in the pelvis&#x000a0;<xref ref-type="bibr" rid="article-31176.r38">[38]</xref>&#x000a0;rather than the lower extremities, as the percentage of isolated pelvic deep venous thrombosis is significantly higher in pregnancy. There are also circulating cytokines and growth factors that may contribute to the breakdown of the endothelial monolayer.<xref ref-type="bibr" rid="article-31176.r39">[39]</xref> In addition, the increase in blood volume and diameter of vessels causes sheer stress on the vessels. This can cause vascular dysfunction and injury by degrading or removing cell junctional proteins.<xref ref-type="bibr" rid="article-31176.r39">[39]</xref>&#x000a0;During pregnancy, the blood becomes hypercoagulable with increased pro-coagulation factors V, VII, VIII, IX, X, XII, and von Willebrand factor.<xref ref-type="bibr" rid="article-31176.r40">[40]</xref> Factor VII increases up to 10-fold, whereas fibrinogen rises 2-fold. There is also a decrease in anticoagulant activity with a reduction in protein S with gestational age, whereas protein C activity remains unchanged.<xref ref-type="bibr" rid="article-31176.r40">[40]</xref>&#x000a0;Fibrinolysis is reduced in pregnancy due to enhanced activity of plasminogen activator inhibitor type I and II and a decreased activity of tissue plasminogen activator. All these factors mentioned above predispose the patient to venous thromboembolism.<xref ref-type="bibr" rid="article-31176.r41">[41]</xref></p>
        <p><bold>Thrombogenesis in Atrial Fibrillation</bold>&#x000a0;</p>
        <p>Atrial fibrillation is the most common supraventricular arrhythmia associated with a high risk of stroke and thromboembolism.<xref ref-type="bibr" rid="article-31176.r42">[42]</xref> There is an increased risk of pathological thrombus formation due to disruption of physiological hemostatic mechanisms, as understood with the help of Virchow's triad.<xref ref-type="bibr" rid="article-31176.r43">[43]</xref> Anatomically, the left atrial appendage is the most common site of intra-atrial thrombus formation in patients with&#x000a0;atrial fibrillation. Disruption/denudation of the extracellular matrix leads to conduction defects (perpetuating atrial fibrillation).<xref ref-type="bibr" rid="article-31176.r42">[42]</xref> It further induces fibrosis and infiltration of the endocardium, thereby promoting thrombogenesis. Abnormal changes in flow are evident by stasis in the left atrium and are seen as spontaneous echo contrast.<xref ref-type="bibr" rid="article-31176.r44">[44]</xref> Some structural changes include progressive atrial dilatation, endocardial denudation, and extracellular matrix fibroblastic infiltration. Additionally, the coagulation cascade increased activation, platelet reactivity, and impaired fibrinolysis due to atrial fibrillation. This process has implicated several prothrombotic biomarkers, including platelet factor 4, von Willebrand factor, fibrinogen, B-thromboglobulin, and D-dimer.<xref ref-type="bibr" rid="article-31176.r45">[45]</xref><xref ref-type="bibr" rid="article-31176.r46">[46]</xref> In summary, These structural changes promote further atrial remodeling and provide a platform for clot formation and subsequent embolization.&#x000a0;</p>
        <p>
<bold>Thrombogenesis in&#x000a0;Left Ventricle Thrombus Post-MI&#x000a0;</bold>
</p>
        <p>The mechanism involving&#x000a0;left ventricle thrombus formation following AMI involves the principle of Virchow's triad. Mechanically, infarct expansion with regional thinning and dilation of the damaged endothelium in the infarct zone begins almost immediately, increases wall stress, and may lead to ventricular aneurysm formation.<xref ref-type="bibr" rid="article-31176.r47">[47]</xref> Blood stasis is primarily driven by&#x000a0;left ventricle dysfunction, reduced ejection fraction, and large apical or anterior&#x000a0;left ventricle akinesis.<xref ref-type="bibr" rid="article-31176.r48">[48]</xref>&#x000a0;Additionally, abnormal flow patterns resulting from regional&#x000a0;left ventricle dysfunction are more closely associated with thrombus formation than normal flow patterns. Combined with the low shear rate in the infarct zone, local tissue injury activates the coagulation system, accumulating fibrin via cross-linking (common pathway), platelets (intrinsic pathway), and erythrocytes, collectively forming the fresh thrombus.<xref ref-type="bibr" rid="article-31176.r49">[49]</xref>&#x000a0;Endothelial injury in AMI triggers an inflammatory and prothrombotic state (ie, hypercoagulability) by exposing subendothelial tissue and collagen to the circulating blood.<xref ref-type="bibr" rid="article-31176.r50">[50]</xref>&#x000a0;&#x000a0;</p>
        <p>Larger infarcts, evidenced by higher levels of cardiac enzymes, have also been associated with increased rates of&#x000a0;left ventricle thrombus formation compared with patients with smaller infarcts. Baseline C-reactive protein, fibrinogen, and the neutrophil-lymphocyte ratio are independent predictors of early&#x000a0;left ventricle thrombus formation after AMI. In this context, the propagation and growth of small thrombi into larger thrombi protruding into the ventricular cavity and exposed to circulating blood flow may lead to embolism.<xref ref-type="bibr" rid="article-31176.r51">[51]</xref> The hypercoagulable state following AMI appears to persist for&#x000a0;6 months or longer. A fresh thrombus may contribute to a persistent inflammatory reaction in the underlying myocardium and is thrombogenic. In contrast, a chronic thrombus is less prone to embolism once it becomes more firmly anchored to the endocardium, more laminar and less protruding, and isolated from the dynamic forces of circulating blood.<xref ref-type="bibr" rid="article-31176.r51">[51]</xref><xref ref-type="bibr" rid="article-31176.r49">[49]</xref>&#x000a0;The physical characteristics of the thrombus (ie, its size, shape, mural [sessile] or protruding morphology, mobility, and age relative to the acute event) may influence its consequences.&#x000a0;</p>
      </sec>
      <sec id="article-31176.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Given the serious nature of thrombosis, an interprofessional healthcare team, including clinicians, nurses, mid-level providers, and specialists, should be familiar with Virchow's triad and recognize the presentation when examining or interacting with patients. Prompt recognition can lead to further testing and specialized intervention, improving patient outcomes. Multiple studies show regular exercise reduces the risk of arterial and venous thrombotic events. One mechanism may be that regular exercise reduces circulating levels of viscosity and hemostatic and inflammatory variables.<xref ref-type="bibr" rid="article-31176.r52">[52]</xref> Encouraging regular exercise and minimizing immobility may reduce the risk of cardiovascular thrombotic events through systemic effects that maintain blood flow.</p>
      </sec>
      <sec id="article-31176.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31176&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31176">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31176/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31176">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31176.s6">
        <title>References</title>
        <ref id="article-31176.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bagot</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Arya</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Virchow and his triad: a question of attribution.</article-title>
            <source>Br J Haematol</source>
            <year>2008</year>
            <month>Oct</month>
            <volume>143</volume>
            <issue>2</issue>
            <fpage>180</fpage>
            <page-range>180-90</page-range>
            <pub-id pub-id-type="pmid">18783400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
            </person-group>
            <article-title>Virchow's triad revisited: blood constituents.</article-title>
            <source>Pathophysiol Haemost Thromb</source>
            <season>2003 Sep-2004 Dec</season>
            <volume>33</volume>
            <issue>5-6</issue>
            <fpage>449</fpage>
            <page-range>449-54</page-range>
            <pub-id pub-id-type="pmid">15692259</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumar</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Hanlin</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Glurich</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Yale</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Virchow's contribution to the understanding of thrombosis and cellular biology.</article-title>
            <source>Clin Med Res</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>3-4</issue>
            <fpage>168</fpage>
            <page-range>168-72</page-range>
            <pub-id pub-id-type="pmid">20739582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Karamanou</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Laios</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsoucalas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Machairas</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Androutsos</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Charles-Emile Troisier (1844-1919) and the clinical description of signal node.</article-title>
            <source>J BUON</source>
            <year>2014</year>
            <season>Oct-Dec</season>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>1133</fpage>
            <page-range>1133-5</page-range>
            <pub-id pub-id-type="pmid">25536635</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cines</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Pollak</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Buck</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Loscalzo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>McEver</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Pober</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Wick</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Konkle</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Barnathan</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>McCrae</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Hug</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Stern</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Endothelial cells in physiology and in the pathophysiology of vascular disorders.</article-title>
            <source>Blood</source>
            <year>1998</year>
            <month>May</month>
            <day>15</day>
            <volume>91</volume>
            <issue>10</issue>
            <fpage>3527</fpage>
            <page-range>3527-61</page-range>
            <pub-id pub-id-type="pmid">9572988</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>B&#x000f8;rsum</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Biochemical properties of vascular endothelial cells.</article-title>
            <source>Virchows Arch B Cell Pathol Incl Mol Pathol</source>
            <year>1991</year>
            <volume>60</volume>
            <issue>5</issue>
            <fpage>279</fpage>
            <page-range>279-86</page-range>
            <pub-id pub-id-type="pmid">1685034</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jaffe</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Cell biology of endothelial cells.</article-title>
            <source>Hum Pathol</source>
            <year>1987</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>234</fpage>
            <page-range>234-9</page-range>
            <pub-id pub-id-type="pmid">3546072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>George</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Brouqui</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Boffa</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mutin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Drancourt</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Brisson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Raoult</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sampol</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever.</article-title>
            <source>Blood</source>
            <year>1993</year>
            <month>Oct</month>
            <day>01</day>
            <volume>82</volume>
            <issue>7</issue>
            <fpage>2109</fpage>
            <page-range>2109-16</page-range>
            <pub-id pub-id-type="pmid">7691249</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esmon</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>The roles of protein C and thrombomodulin in the regulation of blood coagulation.</article-title>
            <source>J Biol Chem</source>
            <year>1989</year>
            <month>Mar</month>
            <day>25</day>
            <volume>264</volume>
            <issue>9</issue>
            <fpage>4743</fpage>
            <page-range>4743-6</page-range>
            <pub-id pub-id-type="pmid">2538457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blann</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Amiral</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>McCollum</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
            </person-group>
            <article-title>Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls.</article-title>
            <source>Atherosclerosis</source>
            <year>2000</year>
            <month>Sep</month>
            <volume>152</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <page-range>29-34</page-range>
            <pub-id pub-id-type="pmid">10996336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Morange</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Simon</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Alessi</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Luc</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Arveiler</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Ferrieres</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Amouyel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ducimetiere</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Juhan-Vague</surname>
                <given-names>I</given-names>
              </name>
              <collab>PRIME Study Group</collab>
            </person-group>
            <article-title>Endothelial cell markers and the risk of coronary heart disease: the Prospective Epidemiological Study of Myocardial Infarction (PRIME) study.</article-title>
            <source>Circulation</source>
            <year>2004</year>
            <month>Mar</month>
            <day>23</day>
            <volume>109</volume>
            <issue>11</issue>
            <fpage>1343</fpage>
            <page-range>1343-8</page-range>
            <pub-id pub-id-type="pmid">15023872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conway</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Pearce</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Chin</surname>
                <given-names>BS</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
            </person-group>
            <article-title>Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation.</article-title>
            <source>Circulation</source>
            <year>2003</year>
            <month>Jul</month>
            <day>01</day>
            <volume>107</volume>
            <issue>25</issue>
            <fpage>3141</fpage>
            <page-range>3141-5</page-range>
            <pub-id pub-id-type="pmid">12796127</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thompson</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Kienast</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pyke</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Haverkate</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>van de Loo</surname>
                <given-names>JC</given-names>
              </name>
            </person-group>
            <article-title>Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.</article-title>
            <source>N Engl J Med</source>
            <year>1995</year>
            <month>Mar</month>
            <day>09</day>
            <volume>332</volume>
            <issue>10</issue>
            <fpage>635</fpage>
            <page-range>635-41</page-range>
            <pub-id pub-id-type="pmid">7845427</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hosseinzadegan</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Tafti</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Prediction of Thrombus Growth: Effect of Stenosis and Reynolds Number.</article-title>
            <source>Cardiovasc Eng Technol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>164</fpage>
            <page-range>164-181</page-range>
            <pub-id pub-id-type="pmid">28470538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levesque</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Nerem</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>The elongation and orientation of cultured endothelial cells in response to shear stress.</article-title>
            <source>J Biomech Eng</source>
            <year>1985</year>
            <month>Nov</month>
            <volume>107</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-7</page-range>
            <pub-id pub-id-type="pmid">4079361</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wasserman</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Topper</surname>
                <given-names>JN</given-names>
              </name>
            </person-group>
            <article-title>Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications.</article-title>
            <source>Vasc Med</source>
            <year>2004</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>35</fpage>
            <page-range>35-45</page-range>
            <pub-id pub-id-type="pmid">15230487</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Danesh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wheeler</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Hirschfield</surname>
                <given-names>GM</given-names>
              </name>
              <name>
                <surname>Eda</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eiriksdottir</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rumley</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lowe</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Pepys</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Gudnason</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.</article-title>
            <source>N Engl J Med</source>
            <year>2004</year>
            <month>Apr</month>
            <day>01</day>
            <volume>350</volume>
            <issue>14</issue>
            <fpage>1387</fpage>
            <page-range>1387-97</page-range>
            <pub-id pub-id-type="pmid">15070788</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brown</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Shantsila</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Varma</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
            </person-group>
            <article-title>Current Understanding of Atherogenesis.</article-title>
            <source>Am J Med</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>130</volume>
            <issue>3</issue>
            <fpage>268</fpage>
            <page-range>268-282</page-range>
            <pub-id pub-id-type="pmid">27888053</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Libby</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Buring</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Badimon</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hansson</surname>
                <given-names>GK</given-names>
              </name>
              <name>
                <surname>Deanfield</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bittencourt</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Tokg&#x000f6;zo&#x0011f;lu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Atherosclerosis.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2019</year>
            <month>Aug</month>
            <day>16</day>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>56</fpage>
            <pub-id pub-id-type="pmid">31420554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Shantsila</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited.</article-title>
            <source>Lancet</source>
            <year>2009</year>
            <month>Jan</month>
            <day>10</day>
            <volume>373</volume>
            <issue>9658</issue>
            <fpage>155</fpage>
            <page-range>155-66</page-range>
            <pub-id pub-id-type="pmid">19135613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cella</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zahavi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>de Haas</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Kakkar</surname>
                <given-names>VV</given-names>
              </name>
            </person-group>
            <article-title>beta-Thromboglobulin, platelet production time and pletelet function in vascular disease.</article-title>
            <source>Br J Haematol</source>
            <year>1979</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>1</issue>
            <fpage>127</fpage>
            <page-range>127-36</page-range>
            <pub-id pub-id-type="pmid">92336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaplan</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo.</article-title>
            <source>Blood</source>
            <year>1981</year>
            <month>Feb</month>
            <volume>57</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-202</page-range>
            <pub-id pub-id-type="pmid">6160890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blann</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
            </person-group>
            <article-title>Hypothesis: is soluble P-selectin a new marker of platelet activation?</article-title>
            <source>Atherosclerosis</source>
            <year>1997</year>
            <month>Feb</month>
            <day>10</day>
            <volume>128</volume>
            <issue>2</issue>
            <fpage>135</fpage>
            <page-range>135-8</page-range>
            <pub-id pub-id-type="pmid">9050769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blann</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GY</given-names>
              </name>
              <name>
                <surname>Beevers</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>McCollum</surname>
                <given-names>CN</given-names>
              </name>
            </person-group>
            <article-title>Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.</article-title>
            <source>Thromb Haemost</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>77</volume>
            <issue>6</issue>
            <fpage>1077</fpage>
            <page-range>1077-80</page-range>
            <pub-id pub-id-type="pmid">9241735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mammen</surname>
                <given-names>EF</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of venous thrombosis.</article-title>
            <source>Chest</source>
            <year>1992</year>
            <month>Dec</month>
            <volume>102</volume>
            <issue>6 Suppl</issue>
            <fpage>640S</fpage>
            <page-range>640S-644S</page-range>
            <pub-id pub-id-type="pmid">1451539</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sevitt</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The structure and growth of valve-pocket thrombi in femoral veins.</article-title>
            <source>J Clin Pathol</source>
            <year>1974</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>7</issue>
            <fpage>517</fpage>
            <page-range>517-28</page-range>
            <pub-id pub-id-type="pmid">4138834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stone</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hangge</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Albadawi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Wallace</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Shamoun</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Knuttien</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Naidu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Oklu</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Deep vein thrombosis: pathogenesis, diagnosis, and medical management.</article-title>
            <source>Cardiovasc Diagn Ther</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>Suppl 3</issue>
            <fpage>S276</fpage>
            <page-range>S276-S284</page-range>
            <pub-id pub-id-type="pmid">29399531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brooks</surname>
                <given-names>EG</given-names>
              </name>
              <name>
                <surname>Trotman</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wadsworth</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Taatjes</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Ittleman</surname>
                <given-names>FP</given-names>
              </name>
              <name>
                <surname>Callas</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Esmon</surname>
                <given-names>CT</given-names>
              </name>
              <name>
                <surname>Bovill</surname>
                <given-names>EG</given-names>
              </name>
            </person-group>
            <article-title>Valves of the deep venous system: an overlooked risk factor.</article-title>
            <source>Blood</source>
            <year>2009</year>
            <month>Aug</month>
            <day>06</day>
            <volume>114</volume>
            <issue>6</issue>
            <fpage>1276</fpage>
            <page-range>1276-9</page-range>
            <pub-id pub-id-type="pmid">19436051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Myers</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Hawley</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Farris</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Wrobleski</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Thanaporn</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schaub</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wakefield</surname>
                <given-names>TW</given-names>
              </name>
            </person-group>
            <article-title>P-selectin and leukocyte microparticles are associated with venous thrombogenesis.</article-title>
            <source>J Vasc Surg</source>
            <year>2003</year>
            <month>Nov</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>1075</fpage>
            <page-range>1075-89</page-range>
            <pub-id pub-id-type="pmid">14603220</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esmon</surname>
                <given-names>CT</given-names>
              </name>
            </person-group>
            <article-title>Basic mechanisms and pathogenesis of venous thrombosis.</article-title>
            <source>Blood Rev</source>
            <year>2009</year>
            <month>Sep</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>225</fpage>
            <page-range>225-9</page-range>
            <pub-id pub-id-type="pmid">19683659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Busch</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cancilla</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>DeBault</surname>
                <given-names>LE</given-names>
              </name>
              <name>
                <surname>Goldsmith</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Owen</surname>
                <given-names>WG</given-names>
              </name>
            </person-group>
            <article-title>Use of endothelium cultured on microcarriers as a model for the microcirculation.</article-title>
            <source>Lab Invest</source>
            <year>1982</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>498</fpage>
            <page-range>498-504</page-range>
            <pub-id pub-id-type="pmid">6752573</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bertina</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Elevated clotting factor levels and venous thrombosis.</article-title>
            <source>Pathophysiol Haemost Thromb</source>
            <season>2003 Sep-2004 Dec</season>
            <volume>33</volume>
            <issue>5-6</issue>
            <fpage>395</fpage>
            <page-range>395-400</page-range>
            <pub-id pub-id-type="pmid">15692250</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosendaal</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>Venous thrombosis: a multicausal disease.</article-title>
            <source>Lancet</source>
            <year>1999</year>
            <month>Apr</month>
            <day>03</day>
            <volume>353</volume>
            <issue>9159</issue>
            <fpage>1167</fpage>
            <page-range>1167-73</page-range>
            <pub-id pub-id-type="pmid">10209995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rao</surname>
                <given-names>LV</given-names>
              </name>
            </person-group>
            <article-title>Tissue factor as a tumor procoagulant.</article-title>
            <source>Cancer Metastasis Rev</source>
            <year>1992</year>
            <month>Nov</month>
            <volume>11</volume>
            <issue>3-4</issue>
            <fpage>249</fpage>
            <page-range>249-66</page-range>
            <pub-id pub-id-type="pmid">1423817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abdollahi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rosendaal</surname>
                <given-names>FR</given-names>
              </name>
            </person-group>
            <article-title>Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use.</article-title>
            <source>Thromb Haemost</source>
            <year>2003</year>
            <month>Mar</month>
            <volume>89</volume>
            <issue>3</issue>
            <fpage>493</fpage>
            <page-range>493-8</page-range>
            <pub-id pub-id-type="pmid">12624633</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbagallo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dominguez</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Licata</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Shan</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bing</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Karpinski</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Pang</surname>
                <given-names>PK</given-names>
              </name>
              <name>
                <surname>Resnick</surname>
                <given-names>LM</given-names>
              </name>
            </person-group>
            <article-title>Vascular Effects of Progesterone : Role of Cellular Calcium Regulation.</article-title>
            <source>Hypertension</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>37</volume>
            <issue>1</issue>
            <fpage>142</fpage>
            <page-range>142-147</page-range>
            <pub-id pub-id-type="pmid">11208769</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tkachenko</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Shchekochikhin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schrier</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Hormones and hemodynamics in pregnancy.</article-title>
            <source>Int J Endocrinol Metab</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>12</volume>
            <issue>2</issue>
            <fpage>e14098</fpage>
            <pub-id pub-id-type="pmid">24803942</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>WS</given-names>
              </name>
              <name>
                <surname>Spencer</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Ginsberg</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Anatomic distribution of deep vein thrombosis in pregnancy.</article-title>
            <source>CMAJ</source>
            <year>2010</year>
            <month>Apr</month>
            <day>20</day>
            <volume>182</volume>
            <issue>7</issue>
            <fpage>657</fpage>
            <page-range>657-60</page-range>
            <pub-id pub-id-type="pmid">20351121</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boeldt</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Bird</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia.</article-title>
            <source>J Endocrinol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>232</volume>
            <issue>1</issue>
            <fpage>R27</fpage>
            <page-range>R27-R44</page-range>
            <pub-id pub-id-type="pmid">27729465</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brenner</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Haemostatic changes in pregnancy.</article-title>
            <source>Thromb Res</source>
            <year>2004</year>
            <volume>114</volume>
            <issue>5-6</issue>
            <fpage>409</fpage>
            <page-range>409-14</page-range>
            <pub-id pub-id-type="pmid">15507271</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>James</surname>
                <given-names>AH</given-names>
              </name>
              <name>
                <surname>Jamison</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Brancazio</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality.</article-title>
            <source>Am J Obstet Gynecol</source>
            <year>2006</year>
            <month>May</month>
            <volume>194</volume>
            <issue>5</issue>
            <fpage>1311</fpage>
            <page-range>1311-5</page-range>
            <pub-id pub-id-type="pmid">16647915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yamashita</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Virchow triad and beyond in atrial fibrillation.</article-title>
            <source>Heart Rhythm</source>
            <year>2016</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>2377</fpage>
            <page-range>2377-2378</page-range>
            <pub-id pub-id-type="pmid">27616698</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ding</surname>
                <given-names>WY</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lip</surname>
                <given-names>GYH</given-names>
              </name>
            </person-group>
            <article-title>Atrial fibrillation and the prothrombotic state: revisiting Virchow's triad in 2020.</article-title>
            <source>Heart</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>106</volume>
            <issue>19</issue>
            <fpage>1463</fpage>
            <page-range>1463-1468</page-range>
            <pub-id pub-id-type="pmid">32675218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincelj</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sokol</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jaksi&#x00107;</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and clinical significance of left atrial spontaneous echo contrast detected by transesophageal echocardiography.</article-title>
            <source>Echocardiography</source>
            <year>2002</year>
            <month>May</month>
            <volume>19</volume>
            <issue>4</issue>
            <fpage>319</fpage>
            <page-range>319-24</page-range>
            <pub-id pub-id-type="pmid">12047783</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kahn</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Solymoss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Flegel</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Nonvalvular atrial fibrillation: evidence for a prothrombotic state.</article-title>
            <source>CMAJ</source>
            <year>1997</year>
            <month>Sep</month>
            <day>15</day>
            <volume>157</volume>
            <issue>6</issue>
            <fpage>673</fpage>
            <page-range>673-81</page-range>
            <pub-id pub-id-type="pmid">9307553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mitusch</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Siemens</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Garbe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sheikhzadeh</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Diederich</surname>
                <given-names>KW</given-names>
              </name>
            </person-group>
            <article-title>Detection of a hypercoagulable state in nonvalvular atrial fibrillation and the effect of anticoagulant therapy.</article-title>
            <source>Thromb Haemost</source>
            <year>1996</year>
            <month>Feb</month>
            <volume>75</volume>
            <issue>2</issue>
            <fpage>219</fpage>
            <page-range>219-23</page-range>
            <pub-id pub-id-type="pmid">8815563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nihoyannopoulos</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Maseri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Foale</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>1989</year>
            <month>Oct</month>
            <volume>14</volume>
            <issue>4</issue>
            <fpage>903</fpage>
            <page-range>903-11</page-range>
            <pub-id pub-id-type="pmid">2794276</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weinsaft</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Medicherla</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Codella</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Kukar</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Alaref</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Devereux</surname>
                <given-names>RB</given-names>
              </name>
            </person-group>
            <article-title>Echocardiographic Algorithm for Post-Myocardial Infarction LV Thrombus: A Gatekeeper for Thrombus Evaluation by Delayed&#x000a0;Enhancement CMR.</article-title>
            <source>JACC Cardiovasc Imaging</source>
            <year>2016</year>
            <month>May</month>
            <volume>9</volume>
            <issue>5</issue>
            <fpage>505</fpage>
            <page-range>505-15</page-range>
            <pub-id pub-id-type="pmid">26476503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stein</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism.</article-title>
            <source>Am J Cardiol</source>
            <year>1989</year>
            <month>Jul</month>
            <day>18</day>
            <volume>64</volume>
            <issue>4</issue>
            <fpage>33B</fpage>
            <page-range>33B-40B</page-range>
            <pub-id pub-id-type="pmid">2665469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Acar</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Ziyrek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Korkmaz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kiris</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Celik</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Mean platelet volume at admission is a determinant of left ventricular thrombus formation after primary percutaneous coronary intervention for first anterior wall myocardial infarction.</article-title>
            <source>Acta Cardiol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>69</volume>
            <issue>6</issue>
            <fpage>603</fpage>
            <page-range>603-9</page-range>
            <pub-id pub-id-type="pmid">25643430</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuster</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Halperin</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Left ventricular thrombi and cerebral embolism.</article-title>
            <source>N Engl J Med</source>
            <year>1989</year>
            <month>Feb</month>
            <day>09</day>
            <volume>320</volume>
            <issue>6</issue>
            <fpage>392</fpage>
            <page-range>392-4</page-range>
            <pub-id pub-id-type="pmid">2913497</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31176.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Posthuma</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>van der Meijden</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Ten Cate</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Spronk</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Short- and Long-term exercise induced alterations in haemostasis: a review of the literature.</article-title>
            <source>Blood Rev</source>
            <year>2015</year>
            <month>May</month>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>171</fpage>
            <page-range>171-8</page-range>
            <pub-id pub-id-type="pmid">25467962</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
